EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A New Radiotranscriptomic Approach to Analyze Combined Sets of T3b Stage‐Specific Genes and Radiomic Features in Prostate Cancer

Qian Yang iD, Peng Tang iD, Jiao Mo iD, Qiuyang Li iD, Jiahui Huang iD, Xiaoyu Han iD, Hao Xu iD, Xi Liu iD, Jie Tang iD

Cancer Reports · 2025

DOI: 10.1002/cnr2.70391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Qian Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Air Force Medical Center, Air Force Military Medical University, Beijing, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Biomarkers, Tumor, Transcriptome. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Social Science Fund of China, Natural Science Basic Research Program of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current clinical staging of prostate cancer (PCa) using the tumor‐node‐metastasis (TNM) system and serum biomarkers remains limited in distinguishing locally advanced (T3b) PCa from organ‐confined (T2c) disease.

Aims

Building on our previous biomarker discovery in differentiating PCa from that of benign prostatic hyperplasia, this study pioneers a radiotranscriptomic model to distinguish T3b stage PCa from T2c stage PCa by integrating contrast‐enhanced ultrasound (CEUS) radiomics with stage‐specific transcriptomic signatures, addressing a critical knowledge gap in precision staging. Methods and Results This prospective study was approved by the review board of Chinese PLA General Hospital (S2021‐565‐01), and all participants provided written informed consent. Transrectal B‐mode ultrasound images and contrast‐enhanced ultrasound images on two imaging planes were prospectively analyzed in 48 patients with biopsy‐confirmed PCa (35 patients with stage T2c and 13 with stage T3b). Textural features were evaluated using microvascular ultrasonography and contrast‐enhanced ultrasound. Radiomic data were then retrieved from all modes. An across‐the‐board investigation of mRNA and miRNA expressions was also performed in the two PCa stages. Six biomarkers (frizzled 4, ribosomal protein S7, ribosomal protein L29, miR‐374c, miR‐9, and miR‐6510) were identified to differentiate T3b stage from T2c stage. The area under the curve (AUC) values of the combined set (AUC = 0.887, 0.956, and 0.996 for random forest, naïve Bayes, and support vector machine, respectively) and radiomic features alone (AUC = 0.921, 0.957, and 0.998, respectively) were found to be more accurate than those of the transcriptomic data alone (AUC = 0.583, 0.716, and 0.898, respectively) or clinical features alone (AUC = 0.585, 0.675, and 0.953, respectively). The PCa gene regulatory network comprised of four miRNAs (miR‐148, miR‐141, miR‐342, and miR‐210) may contribute to accelerating tumor progression.

Conclusion

We established the new radiotranscriptomic signatures specifically optimized for differentiating T3b stage from T2c stage by decoding stage‐specific imaging‐genomic crosstalk. This new approach may overcome TNM staging limitations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBiomarkers, TumorTranscriptomeHumansMaleProspective StudiesAgedNeoplasm StagingUltrasonographyMiddle AgedContrast MediaGene Expression Regulation, NeoplasticGene Expression ProfilingRadiomics

Stichwörter der Autor:innen

prostate cancerradiomicsradiotranscriptomicstexture analysisultrasound

Substanzen

Biomarkers, TumorContrast Media

Autor:innen und Institutionen

  • Department of Ultrasound, Air Force Medical Center, Air Force Military Medical University, Beijing, China.
  • Department of Ultrasound, First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Department of Orthopedics, China Rehabilitation Research Center, Beijing Charity Hospital, Beijing, China.

ORCID-Profile: Qian Yang, Peng Tang, Jiao Mo, Qiuyang Li, Jiahui Huang, Xiaoyu Han, Hao Xu, Xi Liu, Jie Tang

Förderung

  • National Key Research and Development Program of China
  • National Social Science Fund of China
  • Natural Science Basic Research Program of Shaanxi Province

Zitieren

APA

Yang, Q., Tang, P., Mo, J., Li, Q., Huang, J., Han, X., Xu, H., Liu, X., & Tang, J. (2025). A New Radiotranscriptomic Approach to Analyze Combined Sets of T3b Stage‐Specific Genes and Radiomic Features in Prostate Cancer. Cancer Reports. https://doi.org/10.1002/cnr2.70391

Vancouver

Yang Q, Tang P, Mo J, Li Q, Huang J, Han X, et al. A New Radiotranscriptomic Approach to Analyze Combined Sets of T3b Stage‐Specific Genes and Radiomic Features in Prostate Cancer. Cancer Reports. 2025. doi:10.1002/cnr2.70391

BibTeX
@article{Yang2025,
  author = {Yang, Qian and Tang, Peng and Mo, Jiao and Li, Qiuyang and Huang, Jiahui and Han, Xiaoyu and Xu, Hao and Liu, Xi and Tang, Jie},
  title = {A New Radiotranscriptomic Approach to Analyze Combined Sets of T3b Stage‐Specific Genes and Radiomic Features in Prostate Cancer},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70391}
}
Kostenlos starten →